期刊文献+

不同NYHA分级慢性心力衰竭患者NT-proBNP的变化及意义 被引量:5

The changes and significance of NT-proBNP inDifferent NYHA class patients with chronic heart failure
下载PDF
导出
摘要 目的探讨血浆NT-proBNP(氮端前体脑钠肽)浓度变化在慢性心衰患者中的意义。方法选择慢性心力衰竭患者65例,NYHA分级分为Ⅱ-Ⅳ级,正常对照组21例,测定NT-proBNP血浆浓度。结果各组间NT-proBNP差别有统计学意义(P<0.01),NT-proBNP与NYHA分级呈正相关(r=0.509,P<0.01),抗心衰治疗7天后,与入院时相比各心衰组NT-proBNP明显下降(P<0.01)。结论监测NT-proBNP,对慢性心衰的诊断、严重程度的判断、疗效判定是一项快速简便的指标,值得广泛应用于临床心力衰竭患者。 Objective Study the significance of plasma NT-proBNP changes in patients with chronic heart failure.Methods Select 65 cases with chronic heart failure,divided them intoⅡ-Ⅳclass by NYHA class,21 cases without heart failure were included as the control group.Determine their NT-proBNP plasma concentration.Results The differences of NT-proBNP in different group were significant(P0.01);NT-proBNP showed positive correlation with NYHA class(r = 0.509,P0.01);After 7days'Anti-heart failure therapy,compared to the admission the NT-proBNP in each NYHA class decreased significantly(P0.01).Conclusion Monitoring NT-proBNP is a quick and easy evaluation on diagnosing accuratly,judging the severity and determing the efficacy of chronic heart failure.It should widely used in clinical heart failure patients.
作者 孙晶 王玲
出处 《疾病监测与控制》 2011年第12期716-718,共3页 Journal of Diseases Monitor and Control
关键词 氮端前体脑钠肽 心力衰竭 NYHA分级 NT-proBNP heart failure NYHA class
  • 相关文献

参考文献8

  • 1European Society of Hypertension[J].Journal of Hypertension,2007,25 (6):1105-1187.
  • 2Wieczorek SJ,Wu AH,Christenson R,et al.A rapid B-type natriuretic peptide assay accu-rately diagnoses left ventricular dysfunction and heart failure:a multicenter evaluation[J].Am Heart J,2002,144(5):834-839.
  • 3Parab R,V asudevan A,B rensilverJ,et al.Utility of brain natriuritic peptide as a diagnostic tool for congestive heart failure in the elderly[J]. Crit Pathw Cardiol,2005,4 (3):140-144.
  • 4KTJ Yeo,AHB Wu,Fs Apple,et al.Multicenter evaluation of Elecsys pro BNP[J].Clin Chim Acta,2003,338(112):107-115.
  • 5Pember CJ,Johnson ML,Yandle TG, et al.Deconvolution analysis of cardiac natriurefic peptides during acute volume overload[J].Hypertension, 2000,36(3):355-359.
  • 6Hunt PJ,Richards AM,Nicholls MG,et al.Immunoreactive amino-terminal pro-barin natriuretic peptide:a new marker of cardiac impairment[J]. Clin Endocrinology, 1997,47(3):287-296.
  • 7Troughton R W,Frampton C M,Yandle T G, et al.Treatment of heart failure guided by plasma amino terminal brain natriureticpeptide(N-BNP) concentrations [J].Lancet,2000,355 (4210):1126-1130.
  • 8Hervas I,Osea J,Perez-PasTor JL,et al assay of natriuretic peptide type-B(BNP)in heart failure[J]. Nuel Med Commun, 2003,24(1):61-69.

同被引文献46

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部